Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC
Clinical trial NCT03184090 · COMPLETED
Trial details
- NCT number
- NCT03184090
- Sponsor
- MedSIR
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2020-10-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.